Invention Grant
- Patent Title: Substituted quinoxalines as FGFR kinase inhibitors
-
Application No.: US13990193Application Date: 2011-11-29
-
Publication No.: US09145394B2Publication Date: 2015-09-29
- Inventor: Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Steven John Woodhead , Yannick Aime Eddy Ligny , Patrick René Angibaud
- Applicant: Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Steven John Woodhead , Yannick Aime Eddy Ligny , Patrick René Angibaud
- Applicant Address: GB Cambridge
- Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1020179.6 20101129
- International Application: PCT/GB2011/052356 WO 20111129
- International Announcement: WO2012/073017 WO 20120607
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D241/40 ; C07D403/04 ; C07D401/14 ; C07D403/14
Abstract:
The invention relates to new quinoxaline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US09290478B2 Substituted quinoxalines as FGFR kinase inhibitors Public/Granted day:2016-03-22
Information query
IPC分类:
